Thinly traded micro cap Lantheus Holdings (LNTH +15.7%) heads north on average volume. Shares are up over 64% this month, but still down almost 6% for the year. No particular news accounts for the recent move. Longs are, no doubt, hoping for a continued up move.
The company develops diagnostic imaging agents used to assist clinicians in diagnosing cardiovascular and other diseases. It currently markets a portfolio of 14 products, led by DEFINITY, an injectable agent used in ultrasound procedures and TechneLite, a self-contained system that generates the radioisotope technetium.
Pray for A Pain Free Day!